520 This finding emphasizes the importance of considering metabolic status in cancer treatment and the necessity for further research in this area
For example, sitagliptin and vildagliptin treatment could lower systolic blood pressure (SBP) independently of a reduction in blood glucose (Table 1)
You guys are amazing
In 2025 , Novo Nordisk announced positive Phase 3 ESSENCE trial results evaluating semaglutide for early Alzheimers disease, demonstrating potential neuroprotective effects and opening new therapeutic opportunities
Todays article provides a very quick glimpse at a supplement of interest in the world of womens health and is admittedly particularly brief as it was meant as nothing more than an addendum to my previous piece on the best supplements for PCOS ( below) If you are interested in learning more about the state of the evidence around nutrition/supplementation for PCOS and other relevant womens health concerns, Ive attached my most relevant articles below I sincerely hope you find them insightful
Typically, the current practice is for patients with cancer, treated in Asia, to receive both modern treatments (chemotherapy, radiation, immunotherapy, precision medicine) and traditional medicine